- Home
- TOI vs KAPA Comparison
TOI vs KAPA Comparison
Compare TOI & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOI
- KAPA
- Stock Information
- Founded
- TOI 2007
- KAPA 2013
- Country
- TOI United States
- KAPA United States
- Employees
- TOI N/A
- KAPA N/A
- Industry
- TOI Medical/Nursing Services
- KAPA
- Sector
- TOI Health Care
- KAPA
- Exchange
- TOI Nasdaq
- KAPA NYSE
- Market Cap
- TOI 22.6M
- KAPA 19.9M
- IPO Year
- TOI N/A
- KAPA 2024
- Fundamental
- Price
- TOI $0.55
- KAPA $1.73
- Analyst Decision
- TOI Strong Buy
- KAPA Strong Buy
- Analyst Count
- TOI 1
- KAPA 1
- Target Price
- TOI $2.50
- KAPA $9.00
- AVG Volume (30 Days)
- TOI 951.7K
- KAPA 6.1M
- Earning Date
- TOI 11-13-2024
- KAPA 02-23-2025
- Dividend Yield
- TOI N/A
- KAPA N/A
- EPS Growth
- TOI N/A
- KAPA N/A
- EPS
- TOI N/A
- KAPA N/A
- Revenue
- TOI $378,933,000.00
- KAPA N/A
- Revenue This Year
- TOI $29.17
- KAPA N/A
- Revenue Next Year
- TOI $16.43
- KAPA N/A
- P/E Ratio
- TOI N/A
- KAPA N/A
- Revenue Growth
- TOI 22.29
- KAPA N/A
- 52 Week Low
- TOI $0.13
- KAPA $0.85
- 52 Week High
- TOI $2.45
- KAPA $4.00
- Technical
- Relative Strength Index (RSI)
- TOI 84.45
- KAPA N/A
- Support Level
- TOI $0.25
- KAPA N/A
- Resistance Level
- TOI $0.50
- KAPA N/A
- Average True Range (ATR)
- TOI 0.07
- KAPA 0.00
- MACD
- TOI 0.02
- KAPA 0.00
- Stochastic Oscillator
- TOI 81.46
- KAPA 0.00
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.